Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Lombard Medical Company Profile (NASDAQ:EVAR)

Consensus Ratings for Lombard Medical (NASDAQ:EVAR) (?)
Ratings Breakdown: 4 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $8.25 (104.71% upside)

Analysts' Ratings History for Lombard Medical (NASDAQ:EVAR)
Show:
DateFirmActionRatingPrice TargetDetailsShare
2/27/2015BTIG ResearchSet Price TargetBuy$7.00ViewTweet This Rating  Share This Rating on StockTwits
2/27/2015BarclaysLower Price TargetOverweight$9.00 -> $7.00ViewTweet This Rating  Share This Rating on StockTwits
2/27/2015BTIG ResearchReiterated RatingBuy$7.00ViewTweet This Rating  Share This Rating on StockTwits
1/20/2015Credit Suisse Group AGLower Price TargetOutperform$10.50 -> $8.00ViewTweet This Rating  Share This Rating on StockTwits
1/9/2015BarclaysLower Price TargetOverweight$11.00 -> $9.00ViewTweet This Rating  Share This Rating on StockTwits
9/18/2014BTIG ResearchInitiated CoverageBuy$9.00ViewTweet This Rating  Share This Rating on StockTwits
8/21/2014BarclaysLower Price TargetOverweight$12.00 -> $11.00ViewTweet This Rating  Share This Rating on StockTwits
7/29/2014Credit Suisse Group AGInitiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
6/30/2014Credit Suisse Group AGInitiated CoverageOutperform$10.50ViewTweet This Rating  Share This Rating on StockTwits
5/21/2014Jefferies GroupInitiated CoverageBuy$11.00ViewTweet This Rating  Share This Rating on StockTwits
5/20/2014BarclaysInitiated CoverageOverweight$12.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 3/31/2013 forward)